Precision

ANELLO Photonics Unveils Breakthrough in Aerial, Maritime and Terrestrial Navigation: Introducing the ANELLO X3 as the World's Smallest and Lightest Commercially Available 3-Axis Optical Gyroscope IMU

Retrieved on: 
月曜日, 1月 8, 2024
Atmosphere, Partnership, Silicon photonics, Interest, Commander, Defense, Construction, Build automation, Navigation, Slave & Otis, Silicon, Precision, CES, United States Navy, Robotics, Timing

"We are confident that the ANELLO X3 will set a new standard for performance for autonomous solutions and systems operating in GPS-denied or contested environments."

Key Points: 
  • "We are confident that the ANELLO X3 will set a new standard for performance for autonomous solutions and systems operating in GPS-denied or contested environments."
  • Silicon Photonics remains of strategic importance to Tower within which the SiPhOG is a cutting-edge technology with vast potential for both commercial and defense applications.
  • We look forward to continuing this great partnership with Dr. Paniccia and the ANELLO team and contributing to the high-value offering they have developed."
  • To celebrate the launch of the ANELLO X3, ANELLO Photonics is offering exclusive opportunities for partnerships and collaborations.

United States Anti Jamming Market Research Report 2023-2028: Examine the Evolving Threat Landscape and Growing Jamming Capabilities

Retrieved on: 
金曜日, 1月 5, 2024
Government, Forecast, Private, Critical infrastructure, Government agency, Agriculture, GPS, Telecommunications, Research, Private sector, Artificial intelligence, Defense, Competition, Investment, Machine learning, Organization, Face, Growth, Precision, Transport, Safety, Aviation, Data collection, Communication, Satellite navigation device

DUBLIN, Jan. 5, 2024 /PRNewswire/ -- The "United States Anti Jamming Market, Competition, Forecast & Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 5, 2024 /PRNewswire/ -- The "United States Anti Jamming Market, Competition, Forecast & Opportunities, 2018-2028" report has been added to ResearchAndMarkets.com's offering.
  • The United States anti-jamming market is a critical and rapidly evolving sector within the country's defense and communications landscape.
  • Evolving Threat Landscape and Growing Jamming Capabilities:
    The threat of interference and jamming is not limited to traditional state actors but also extends to rogue nations, terrorist organizations, and individuals with access to jamming devices.
  • The Northeast United States leads the market, benefitting from a dense concentration of defense contractors, research institutions, military facilities, and economic significance.

Precision Drilling Meets 2023 Debt Repayment and Share Repurchase Targets and Provides Capital Allocation, Financial and Operational Updates

Retrieved on: 
金曜日, 1月 5, 2024
Kingdom, Share repurchase, Acquisition, Precision Drilling, CWC, Disclosure, News, PD, PDS, Adjustment, TSX, Precision, Security (finance)

Precision Drilling Corporation (“Precision” or the “Company”) (TSX:PD; NYSE:PDS) is pleased to provide a series of positive announcements including: 1) 2023 debt repayment and year-end liquidity update; 2) capital allocation framework update; and 3) financial and operational update.

Key Points: 
  • Precision Drilling Corporation (“Precision” or the “Company”) (TSX:PD; NYSE:PDS) is pleased to provide a series of positive announcements including: 1) 2023 debt repayment and year-end liquidity update; 2) capital allocation framework update; and 3) financial and operational update.
  • Precision reduced total debt by $152 million in 2023, meeting its debt reduction goal.
  • During 2023, Precision returned $30 million to shareholders through share repurchases under our Normal Course Issuer Bid and as at December 31, 2023, had 14,336,539 shares outstanding.
  • With a robust free cash flow outlook, we plan to improve our capital returns to shareholders in 2024 by increasing our debt reduction and share buyback allocations.

H&E Equipment Services, Inc. Completes Acquisition of Precision Rentals

Retrieved on: 
火曜日, 1月 2, 2024
Other Construction & Property, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Building Systems, Urban Planning, REIT, Acquisition, Growth, Precision, H&E

H&E Equipment Services, Inc. (“H&E” or the “Company”) (NASDAQ: HEES) today announced the completion of its acquisition of the business of Precision Rentals (“Precision”).

Key Points: 
  • H&E Equipment Services, Inc. (“H&E” or the “Company”) (NASDAQ: HEES) today announced the completion of its acquisition of the business of Precision Rentals (“Precision”).
  • The acquisition improves H&E’s branch density in the Phoenix and Denver metropolitan areas and adds a young and attractive mix of equipment totaling approximately $70 million in original equipment cost.
  • This strong growth has been accomplished through our successful warm start program and the acquisition of attractive and well-managed companies, such as Precision, with its excellent operations in Phoenix and Denver, and the surrounding areas.
  • These two promising geographic regions are identified among the 20 largest metropolitan statistical areas in the U.S. and represent excellent non-residential construction potential.

Precision BioSciences Announces Approval of First Clinical Trial Application of ARCUS Gene Insertion Program by Partner iECURE

Retrieved on: 
水曜日, 12月 13, 2023
Research, Infectious Diseases, Genetics, Clinical Trials, Biotechnology, Health, Pharmaceutical, General Health, Science, Precision BioSciences, Nerve, Gene editing, Ornithine transcarbamylase deficiency, HDR, Gene, Clinical trial, Coma, IND, Liver, Disease, Risk, Patient, Cell, ESGCT, Blood, Hepatocyte, Primate, CRISPR, Ammonia, Death, Neurology, Congress, CTA, OTC, Precision, Metabolic disorder, Vaccine

“The acceptance of iECURE’s Clinical Trial Application marks an important milestone for patients with OTC deficiency and for both the iECURE and Precision BioSciences teams.

Key Points: 
  • “The acceptance of iECURE’s Clinical Trial Application marks an important milestone for patients with OTC deficiency and for both the iECURE and Precision BioSciences teams.
  • This is the first ARCUS in vivo gene editing program to progress into the clinic,” said Michael Amoroso, Chief Executive Officer of Precision Biosciences.
  • A 5% threshold of enzymatic activity has the potential for clinical benefit as previously identified in Annals of Clinical and Translational Neurology .
  • “ECUR-506 is the first of several partnered and wholly owned gene editing programs leveraging ARCUS in differentiated indications and we look forward to initial clinical data from this program.”

Global Precision Oncology Market Trends and Growth Opportunities Report 2023: Increasing Adoption of Theranostics, Integrated Cancer Data Platforms, AI for Treatment Planning and Selection - ResearchAndMarkets.com

Retrieved on: 
月曜日, 12月 11, 2023
Health, Oncology, Growth, Drug resistance, Biomarker, Diagnosis, AI, A-DNA, Patient, Knowledge, Robotics, Prognosis, Precision, Cancer, Pharmaceutical industry, Medical imaging

The "Global Precision Oncology Market Trends and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Precision Oncology Market Trends and Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • The study also highlights some of the key market drivers and restraints, partnerships, and present and future market trends that affect the growth of the market.
  • Precision oncology aims to provide oncologists with diagnosis, prognosis, and treatment tools to tailor the treatment according to patients' genetic makeup.
  • The study will provide emerging growth opportunities for the market based on clinical need, use cases, business models, preventive care, market access strategies, and technology trends.

AGCO Brands Win Six 2024 AE50 Awards

Retrieved on: 
水曜日, 12月 6, 2023
Engineering, Other Natural Resources, Manufacturing, Agriculture, Natural Resources, Machinery, Massey Ferguson, AGCO Power, CVT, NYSE, AGCO, S series, RPM, Multimedia, PWM, Span, Peter Hancock (professor), Fruit, Series, Farmer, ECO, World Ag Expo, AWD, Environment, Society, MF, Soil, ASABE, College of Engineering (KNUST), Precision, Vario, Electric motor

AGCO Corporation (NYSE: AGCO), a global leader in the design, manufacture, and distribution of agricultural machinery and precision ag technology, announced today that six of its products and solutions have been recognized with prestigious 2024 AE50 awards from the American Society of Agricultural and Biological Engineers (ASABE) .

Key Points: 
  • AGCO Corporation (NYSE: AGCO), a global leader in the design, manufacture, and distribution of agricultural machinery and precision ag technology, announced today that six of its products and solutions have been recognized with prestigious 2024 AE50 awards from the American Society of Agricultural and Biological Engineers (ASABE) .
  • AGCO’s 2024 awards span its Fendt®, Massey Ferguson® and Precision Planting® brands, confirming consistent excellence across its product lines and cementing the company as agriculture’s leading innovator of farmer-focused solutions.
  • View the full release here: https://www.businesswire.com/news/home/20231206827750/en/
    AGCO announced that six of its products and solutions won the prestigious 2024 AE50 Award for innovation and engineering excellence.
  • (Photo: Business Wire)
    “AGCO is greatly honored by ASABE’s recognition again this year,” said Eric Hansotia, AGCO President, Chairman, and Chief Executive Officer.

Precision BioSciences to Present at Hep-DART 2023

Retrieved on: 
木曜日, 11月 30, 2023
Research, Infectious Diseases, Genetics, Clinical Trials, Biotechnology, General Health, Pharmaceutical, Health, Science, Oncology, Precision BioSciences, Safety, Gene editing, Entrepreneurship, Precision, Vaccine

Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that the company will present at Hep-DART 2023 in an industry session and host a poster presentation on December 5, 2023, in Los Cabos, Mexico.

Key Points: 
  • Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that the company will present at Hep-DART 2023 in an industry session and host a poster presentation on December 5, 2023, in Los Cabos, Mexico.
  • Presenters: Jeff Smith, Co-Founder and Chief Research Officer, Precision BioSciences; Emily Harrison, HBV Research Lead, Precision BioSciences
    Title: “Preclinical efficacy and safety of ARCUS-POL nucleases for chronic hepatitis B: a potentially curative strategy”

Precision BioSciences Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
火曜日, 11月 28, 2023
Other Health, Research, General Health, Pharmaceutical, Oncology, Infectious Diseases, Genetics, Clinical Trials, Science, Biotechnology, Other Science, Health, Common stock, Precision BioSciences, Employment, Gene editing, Compensated emancipation, Precision, Pharmaceutical industry, Lease

Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that, on November 21, 2023, the Compensation Committee of Precision’s Board of Directors approved the grant of an inducement award to a new employee under the Precision BioSciences, Inc. 2021 Employment Inducement Incentive Award Plan (“Inducement Award Plan”).

Key Points: 
  • Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that, on November 21, 2023, the Compensation Committee of Precision’s Board of Directors approved the grant of an inducement award to a new employee under the Precision BioSciences, Inc. 2021 Employment Inducement Incentive Award Plan (“Inducement Award Plan”).
  • The inducement award consists of an option to purchase (“stock option”) 160,000 shares of Precision’s common stock, par value $0.000005 (the “Common Stock”), which was granted to an employee in connection with their commencement of employment.
  • The stock option was granted under Nasdaq Listing Rule 5635(c)(4) as an inducement for the employee to commence service with Precision.
  • The stock option has a per share exercise price equal to the fair market value of Precision’s Common Stock on the grant date, which was equal to $0.42.

AGCO’s Innovative and Sustainable Machines Win Big at Agritechnica

Retrieved on: 
水曜日, 11月 22, 2023
Other Natural Resources, Technology, Manufacturing, Agritech, Agriculture, Natural Resources, Machinery, Farmer, XCMG, Heart, NYSE, Precision, AGCO

AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, and its family of leading brands, received six major awards at the world’s largest trade fair for agricultural machinery, Agritechnica 2023.

Key Points: 
  • AGCO (NYSE: AGCO), a global leader in the design, manufacture and distribution of agricultural machinery and precision ag technology, and its family of leading brands, received six major awards at the world’s largest trade fair for agricultural machinery, Agritechnica 2023.
  • Included in the recognitions – which were decided based on votes cast by committees of independent experts and by the Agritechnica attendees themselves – are top awards recognizing Fendt® and Precision Planting®.
  • This press release features multimedia.
  • View the full release here: https://www.businesswire.com/news/home/20231122988483/en/
    Radicle Agronomics wins the Silver Agritechnica Innovation Award (Photo: Business Wire)
    “I am proud of the hard work these teams have put in to provide farmers with more sustainable solutions throughout the crop cycle,” said Eric Hansotia, Chairman, President and Chief Executive Officer of AGCO.